HOME >> BIOLOGY >> NEWS
Scientists follow familiar TRAIL to new cancer therapy

A new study identifies a combination therapy that may sensitize human cancer cells to a promising treatment currently being used in clinical trials. The research, published in the July issue of the journal Cancer Cell, published by Cell Press, provides a pharmacological method for enhancing the potency and effectiveness of a tumor necrosis factor (TNF) death receptor ligand against a variety of human cancers.

Potency and lack of toxicity to normal tissues make activation of TNF-a-related apoptosis-inducing ligand (TRAIL) death receptor signaling an attractive and exciting target for cancer therapy, and it is currently being tested in clinical trials. However, most cancer cells have defects in their ability to die via a cell death pathway called apoptosis, and unfortunately, TRAIL therapy is not effective in cells that have certain defects in apoptotic pathways. Dr. Wafik S. El-Deiry from the University of Pennsylvania School of Medicine and colleagues designed a series of studies to gain a better understanding of TRAIL-associated cell signaling pathways in cancer cells and to look for ways to pharmacologically optimize TRAIL therapy.

Dr. El-Deirys group had previously established that c-Myc is a key mediator of TRAIL-induced apoptosis and that cancer cells lacking c-Myc and a functional apoptotic pathway were resistant to TRAIL. In the current study, the researchers demonstrated that expression of c-Myc in TRAIL-resistant human colon cancer cells sensitized the cells to TRAIL, even when the cells had intrinsic apoptotic defects. The researchers observed that TRAIL induced expression of two potent antiapoptotic molecules, Mcl-1 and cIAP2, and that c-Myc repressed both molecules.

The researchers also discovered that the multikinase inhibitor sorafenib prevented TRAIL-mediated induction of Mcl-1 and cIAP2, and although it had little effect on the killing of TRAIL-resistant cells when administered alone, combination with TRAIL caused
'"/>

Contact: Erin Doonan
edoonan@cell.com
617-397-2802
Cell Press
9-Jul-2007


Page: 1 2

Related biology news :

1. Scientists show that mitochondrial DNA variants are linked to risk factors for type 2 diabetes
2. Scientists prove that disputed Korean stem cell line comes from an unfertilized egg and not cloning
3. Scientists move closer to bio-engineered bladders
4. Scientists find stem cell switch
5. Scientists discover new way to study nanostructures
6. Scientists a step closer to understanding how anaesthetics work in the brain
7. Scientists to make news at Computational Biology Conference
8. Accident-prone? Scientists link brain function to knee injuries
9. Scientists take next step in understanding potential target for ovarian cancer treatment
10. Scientists find brown fat master switch
11. Scientists identify 2 distinct Parkinsons networks

Post Your Comments:
*Name:
*Comment:
*Email:


(Date:2/22/2019)... ... February 21, 2019 , ... On January 7th, ... SacroFuse system in conjunction with NanoFUSE’s Orthobiologic during a surgery at ... time that either SacroFuse or NanoFUSE have been used in Latin America. ...
(Date:2/19/2019)... ... February 20, 2019 , ... ... out across the organization. Dimensions provides in-depth data, visualizations, and analytics to ... planning, and understand past and future funding activity. , Developed in collaboration ...
(Date:2/19/2019)... ... February 18, 2019 , ... ... technologies and development solutions for drugs, biologics and consumer health products, today ... external business partner recognition, the External Business Partner of the Year Award. ...
Breaking Biology News(10 mins):
(Date:3/9/2019)... ... March 08, 2019 , ... OnlineMasters.com, ... the release of their Best Online Master's in Biotechnology Programs for 2019. ... quality, program flexibility, affordability, and graduate outcomes. , In addition to insights ...
(Date:3/5/2019)... ... March 05, 2019 , ... ... engineering firm with regulatory filing authorities, logistics network experts, and experienced integrated staffing ... its participation in the Inc. Verified Profile program, Inc. editors independently reviewed the ...
(Date:2/27/2019)... SAN DIEGO, CALIF. (PRWEB) , ... February 27, ... ... is expanding its service offering. Starting today, the San Diego-based team-building and ... of 30 people or more: Tacos + Tequila. , This fun-filled, interactive team-building ...
(Date:2/26/2019)... , ... February 26, 2019 , ... ... when Visikol Co-Founder Dr. Thomas Villani developed the Visikol® tissue clearing technology for ... has since transitioned from a products focused company to primarily a services focused ...
Breaking Biology Technology:
Cached News: